按药品类型、产品类型和地区分類的网路药局市场（2026-2032 年）

网路药局市场评估（2026-2032）

智慧型手机和网路连线的普及使得更多人可以更方便地在线购买药品，让顾客可以在自己舒适的家中方便地获得处方笺和非处方药。其次，新冠疫情推动医疗服务数位化不断提升，远端医疗和线上问诊越来越被广泛接受，将推动网路药局服务需求在 2024 年超过 809.6 亿美元，并在 2032 年达到 2,425.4 亿美元。

对个人化医疗和药物管理的日益关注正在推动网路药局交付的创新，例如提供客製化的药物提醒和健康监测工具，从而在竞争日益激烈的市场中提高客户满意度和忠诚度，预计从 2026 年到 2032 年的复合年增长率约为 14.70%。

网路药局市场定义/概述

网路药局网路药局是透过网路平台在线销售和分销药品和健康相关产品。这项策略使顾客可以在自己舒适的家中轻鬆获得处方药和非处方药、保健品和个人保健产品。网路药局应用包括线上处方笺续药、远端医疗咨询、健康监测服务以及直接向客户送药。网路药局的未来是乐观的，数位健康技术的进步、互联网接入的增加以及对高效医疗保健解决方案的需求不断增长预计将推动其发展。随着药品网上销售规则的出台以及消费者对电子健康益处的认识不断提高，网路药局业务将迅速扩张，提供更个人化的服务和更好的客户体验。

对个人化医疗的日益重视是否会推动网路药局市场的发展？

随着对个人化医疗的日益关注，网路药局产业预计将大幅成长。随着科技的进步，网路药局正在利用数据分析和人工智慧提供个人化的药物和健康建议，提高患者的参与度和幸福感。 2023 年 9 月，远端医疗平台 Teladoc Health 宣布启动一项新的个人化医疗计划，旨在根据独特的患者资料加强治疗计划。此举反映了业界朝着个人化医疗发展的更广泛趋势，并表明网路药局能够很好地满足客製化健康解决方案的需求。

例如，2023年7月，美国食品药物管理局（FDA）发布指南，鼓励使用数位健康技术支援个人化医疗，强调将此类方法纳入现有医疗保健系统的必要性。根据 Verified Market Research 的预测，由于个人化医疗服务需求的不断增长，网路药局市场将在 2024 年至 2032 年期间以 14.70% 的复合年增长率发展。随着消费者对个人化医疗保健解决方案的需求，技术创新与正确的法律体制的结合将有助于网路药局产业的发展。

药品销售监管日益严格是否会阻碍网路药局市场的成长？

药品销售法规的日益增加可能会阻碍网路药局业务的扩张，因为遵守各种法律将成为网路药局面临的主要障碍。许多国家的监管机构都制定了严格的标准来确保药品安全，包括许可、药品品质监控和保护病患隐私。网路药局必须管理这些复杂的规定，这会增加营运成本和管理麻烦。小型企业尤其可能难以达到这些标准，导致市场竞争和创新减少。此外，违规的风险可能会阻碍新进入网路药局市场的参与企业，从而限制其整体成长前景。

虽然严格的规定可能是一个障碍，但它们也有助于提高客户的信任和安全，这可能对长期的市场成长产生积极的影响。有了更完善的法律规范，消费者可能会更有信心在网路上订购药品，从而增加对信誉良好的网路药局服务的需求。在这种环境下，成功遵守法规的网路药局有可能透过提高声誉和信誉来实现差异化并增加市场占有率。最终，加强监管对网路药局业务的影响将取决于公司在维持用户参与和服务品质的同时如何适应合规需求。

目录

第一章 全球网路药局市场概览

• 市场概览
• 分析范围
• 先决条件

第二章执行摘要

第三章 已验证的市场研究分析方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章 全球网路药局市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章 全球网路药局市场（依药品类型划分）

• 概述
• 处方药
• OTC（场外交易）

6. 全球网路药局市场（依产品类型）

• 概述
• 护肤
• 牙科
• 感冒和流感
• 维他命
• 其他的

7. 全球网路药局市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第八章全球网路药局市场的竞争格局

• 概述
• 企业市场排名
• 供应商格局
• 主要发展策略

第九章 公司简介

• CVS Health Corporation
• DocMorris
• Express Scripts Holding Company
• Giant Eagle Inc.
• Optum Rx Inc.
• Rowlands Pharmacy
• The Kroger Co.
• Walgreen Co.
• Walmart Stores Inc

第十章 附录

• 相关分析

E Pharmacy Market Valuation - 2026-2032

The growing use of smartphones and internet connectivity has made online medication shopping more accessible to a wider audience, allowing customers to conveniently obtain prescriptions and over-the-counter drugs from the comfort of their own homes. Second, the ongoing digitization of healthcare services, spurred by the COVID-19 pandemic, has led to a wider acceptance of telehealth and online consultations, increasing demand for e-pharmacy services is surpassing USD 80.96 Billion in 2024 and reaching USD 242.54 Billion by 2032.

The growing emphasis on personalized healthcare and medication management has prompted e-pharmacies to innovate their service offerings, such as providing customized medication reminders and health monitoring tools, thereby increasing customer satisfaction and loyalty in an increasingly competitive market is expected to grow at a CAGR of about 14.70% from 2026 to 2032.

E Pharmacy Market: Definition/ Overview

E-pharmacy, or electronic pharmacy, is the online selling and distribution of pharmaceuticals and health-related items via internet-based platforms. This strategy enables customers to easily obtain prescription and over-the-counter pharmaceuticals, health supplements, and personal care products from the comfort of their own homes. E-pharmacy applications include online prescription refills, telemedicine consultations, health monitoring services, and direct pharmaceutical delivery to customers. The future of e-pharmacy seems optimistic, with development expected to be driven by advances in digital health technologies, increased internet access, and rising demand for efficient healthcare solutions. As rules adapt to allow online pharmaceutical sales and consumer awareness of e-health benefits grows, the e-pharmacy business is likely to increase rapidly, providing more personalized services and improved customer experiences.

Will Growing Emphasis on Personalized Healthcare Drive the E Pharmacy Market?

The growing emphasis on personalized healthcare is expected to fuel significant growth in the e-pharmacy industry, as customers seek tailored solutions to meet their individual health demands. With technological improvements, e-pharmacies are using data analytics and artificial intelligence to give personalized drug regimens and health recommendations, hence increasing patient engagement and happiness. In September 2023, Teladoc Health, a telehealth platform, announced the introduction of a new personalized medicine project aiming at enhancing treatment plans based on unique patient profiles. This move mirrors a broader industry trend toward personalized healthcare, implying that e-pharmacies are well-positioned to address the demand for customized health solutions.

For instance, in July 2023, the US Food and Drug Administration (FDA) issued guidelines encouraging the use of digital health technologies to support personalized medicine, highlighting the necessity of incorporating these approaches into existing healthcare systems. According to Verified Market Research, the e-pharmacy market will develop at a CAGR of 14.70% between 2024 and 2032, driven by increased demand for individualized healthcare services. This convergence of technical innovation and appropriate legal frameworks sets the e-pharmacy sector for growth as consumers desire personalized healthcare solutions.

Will Growing Regulations Regarding the Sale of Pharmaceuticals Hamper the Growth of the E Pharmacy Market?

Growing rules governing the selling of medications may stymie the expansion of the e-pharmacy business, as complying with various laws creates substantial obstacles for online pharmacies. Many countries' regulatory agencies have created severe criteria to assure medicine safety, such as licensing verification, drug quality monitoring, and patient privacy protection. E-pharmacies must manage these complex rules, which can raise operating costs and administrative hassles. Smaller companies, in particular, may struggle to fulfill these criteria, resulting in less competition and innovation in the market. Furthermore, the risk of non-compliance can dissuade new participants from entering the e-pharmacy market, restricting overall growth prospects.

While strict rules may provide obstacles, they also help to increase customer trust and safety, which could have a positive impact on long-term market growth. As regulatory frameworks become more established, consumers may gain confidence in ordering pharmaceuticals online, increasing demand for reputable e-pharmacy services. In this environment, e-pharmacies that successfully comply with rules may distinguish themselves through increased reputation and reliability, potentially acquiring a larger share of the market. Finally, the impact of increased restrictions on the e-pharmacy business will be determined by how well enterprises adapt to compliance needs while preserving user engagement and service quality.

Category-Wise Acumens

Will Rising Demand of Prescription Drugs Propel the E Pharmacy Market?

The increasing demand for prescription pharmaceuticals is expected to considerably boost the growth of the e-pharmacy industry, owing to factors such as increased chronic disease prevalence and the convenience of online ordering. As more patients require continuing medicine for ailments such as diabetes, hypertension, and mental health difficulties, e-pharmacies are well-positioned to address this growing demand by giving convenient access to important drugs. For instance, in September 2023, CVS Health declared a strategic focus on increasing its digital health services, highlighting the necessity of online prescriptions to improve patient access and drug management. This move highlights the synchronization of traditional pharmacy operations with consumers' changing requirements, demonstrating how established enterprises are shifting to capitalize on the e-pharmacy boom.

Furthermore, government initiatives promoting telehealth and digital healthcare solutions boost the e-pharmacy market's growth prospects. For instance, in April 2023, the United States Department of Health and Human Services (HHS) issued new guidelines to make telehealth services, such as online prescription refills, more accessible, particularly for mental health and substance use issues. These regulations aim to increase healthcare access for marginalized groups, which will have a direct influence on the e-pharmacy business by encouraging more patients to use online services for their prescriptions.

In contrast, the over-the-counter (OTC) pharmaceuticals segment is the fastest-growing category, driven by rising consumer awareness of health and wellness, as well as the convenience of ordering OTC meds online. The growing tendency of self-medication, particularly among younger consumers who prefer the convenience of online purchase, is driving this segment's expansion.

Will Rising Cases of Cold and Flu Drive the Growth of E Pharmacy Market?

The rising number of cold and flu cases is expected to generate significant growth in the e-pharmacy market, as more consumers seek easy and rapid access to over-the-counter pharmaceuticals and health items online. With a growing occurrence of respiratory illnesses, particularly during seasonal peaks, e-pharmacies are becoming a popular choice for those who want to treat their symptoms without having to visit a real pharmacy. In October 2023, Walgreens reported an increase in online sales of cold and flu treatments, reflecting consumer preferences toward seeking fast relief via digital platforms. The convenience of online buying, especially during illness when going out may be less tempting, allows e-pharmacies to grab a higher market share in this area.

For instance, in September 2023, the Centers for Disease Control and Prevention (CDC) initiated a campaign advocating vaccination and early treatment of flu symptoms, resulting in increased consumer demand for cold and flu treatments. The emphasis on accessibility and quick reaction to disease is well aligned with the ability of e-pharmacies to deliver health supplies directly to consumers' homes.

However, the skin care area is emerging as the fastest-growing category, owing to increased consumer interest in personal wellbeing, cosmetic products, and preventative healthcare. With the rise of social media and online beauty trends, more people are turning to e-pharmacies for skincare solutions, which include both medicinal and cosmetic items. This shift toward skin health and wellbeing reflects a substantial change in consumer behavior, setting the skin care category for strong growth in the e-pharmacy market.

Country/Region-wise

Will Widespread Internet Penetration in North America Drive the E Pharmacy Market?

The high internet access in North America is a major driver of the e-pharmacy sector. As of 2023, the Internet and Mobile Association of North America claimed that internet penetration in the region had reached 94.6%, with 392 million people routinely accessing online services. This high level of connection has made the environment ideal for the growth of e-pharmacy services. In February 2024, the Federal Communications Commission (FCC) revealed that 99% of Americans now have broadband internet connection, up from 93.5% in 2020. This enhanced accessibility has enabled more consumers to use online pharmacy services, particularly in rural areas where physical pharmacies are less accessible. The ease of obtaining prescriptions online, together with the opportunity to readily compare prices and access health information, has led to a surge in e-pharmacy adoption.

In March 2024, Amazon Pharmacy reported a 45% year-over-year rise in prescription orders, citing greater internet access and shifting consumer preferences. Similarly, CVS Health said in January 2024 that their digital pharmacy revenues had increased by 38% over the previous year, accounting for 25% of all prescription fills. On the regulatory front, the U.S. Food and Drug Administration (FDA) published new rules in September 2023 to make it easier for e-pharmacies to obtain licenses in several states, with the goal of facilitating the growth of online pharmacy services. A poll done by the National Association of Boards of Pharmacy in July 2023 indicated that 62% of North American customers have used an online pharmacy service at least once in the previous year.

Will Rising Demand for Convenient Access to Medications in Asia-Pacific Propel the E Pharmacy Market?

The Asia-Pacific region's increased desire for convenient drug access is expected to considerably accelerate the e-pharmacy industry, led by a growing population that is increasingly reliant on digital healthcare solutions. As more consumers in this region adopt online shopping and mobile applications, the e-pharmacy sector stands to benefit from the desire for convenient access to both prescription and over-the-counter drugs. For instance, in August 2023, India-based e-pharmacy PharmEasy reported a 60% growth in online medication orders, owing to a growing preference for home delivery. This trend demonstrates the region's shift toward digital healthcare solutions, as well as how convenience influences customer behavior.

Furthermore, government initiatives in the Asia-Pacific region are boosting the e-pharmacy market's growth prospects. In June 2023, the Chinese government issued new policies to promote the digitalization of healthcare services, including online pharmaceutical sales, with the goal of improving access for rural communities.

Competitive Landscaped

The competitive landscape of the e-pharmacy market is characterized by a dynamic interplay of established pharmacy chains, technology-driven startups, and online healthcare service providers. This market features a mix of local and global players, each vying for a share through innovative services, competitive pricing, and extensive product offerings. Companies are increasingly focusing on enhancing customer experience through user-friendly mobile apps and websites, along with personalized services such as telehealth consultations and medication reminders. Additionally, strategic partnerships and collaborations with healthcare providers and technology firms are becoming common as e-pharmacies seek to expand their reach and improve service delivery. Regulatory compliance and maintaining quality standards are also critical factors that influence competitive positioning in this rapidly evolving sector.

Some of the prominent players operating in the E pharmacy market include:

CVS Health Corporation

DocMorris

Express Scripts Holding Company

Giant Eagle,

Optum Rx,

Rowlands Pharmacy

The Kroger Co.

Walgreen Co.

Walmart Stores,

Latest Developments

In August 2023, Walgreens announced the development of its digital health services, with an emphasis on improving its e-pharmacy platform. In response to the increased demand for online healthcare solutions, the firm plans to improve the user experience with an upgraded mobile app that makes prescription refills and medication monitoring easier.

In September 2023, India-based e-pharmacy PharmEasy announced a strategic agreement with local healthcare providers to deliver individualized drug management services. This alliance seeks to improve patient participation and ensure timely delivery of critical medications, reflecting the growing emphasis on individualized healthcare solutions.

E Pharmacy Market, By Category

• Drug Type:
• Prescription Drugs
• Over the Counter Drugs
• Product Type:
• Skin Care
• Dental
• Cold
• Flu
• Vitamins
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL E Pharmacy MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL E Pharmacy MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL E Pharmacy MARKET, BY DRUG TYPE

• 5.1 Overview
• 5.2 Prescription Drugs
• 5.3 Over-the-counter (OTC) Drugs

6 GLOBAL E Pharmacy MARKET, BY PRODUCT TYPE

• 6.1 Overview
• 6.2 Skin Care
• 6.3 Dental
• 6.4 Cold and Flu
• 6.5 Vitamins
• 6.6 Others

7 GLOBAL E Pharmacy MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5. Rest of the World
  • 7.5.1. Latin America
  • 7.5.2. Middle East & Africa

8 GLOBAL E Pharmacy MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market ranking
• 8.3 Vendor Landscape
• 8.4 Key Development Strategies

9 COMPANY PROFILES

• 9.1 CVS Health Corporation
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 DocMorris
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Express Scripts Holding Company
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Giant Eagle Inc.
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Optum Rx Inc.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Rowlands Pharmacy
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 The Kroger Co.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Walgreen Co.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Walmart Stores Inc
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments

10 APPENDIX

• 10.1 Related Research